Recent insights into body weight control: From physiology to pathology

Journal of Peptide Science

Volumn 7, Issue 11, 2001, Pages 571-578

  Krysiak, Robert ^a   Okopie, Bogusaw ^a   Belowski, Dariusz ^a   Madej, Andrzej ^a   Herman, Zbigniew Stanisaw ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Body weight; Corticotropin releasing hormone (CRH); Feeding; Leptin; Melanocortins; Neuropeptide Y (NPY); Obesity

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AGOUTI PROTEIN; ALPHA MELANOTROPIN[4-10]; AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; ANOREXIGENIC AGENT; ANTISENSE OLIGONUCLEOTIDE; APPETITE STIMULANT; COCAINE REGULATED TRANSCRIPT PEPTIDE; CORTICOTROPIN RELEASING FACTOR; FENFLURAMINE; FLUOXETINE; HORMONE ANALOG; HSO 024; HSO 14; HSO 24; LEPTIN; MELANIN CONCENTRATING HORMONE; MELANOCORTIN; MELANOCORTIN RECEPTOR; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; NEUROHORMONE; NEUROPEPTIDE; NEUROPEPTIDE Y; OREXIN; OREXIN A; OREXIN B; PEPTIDE; RECEPTOR BLOCKING AGENT; RECOMBINANT LEPTIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; UROCORTIN;

ANIMAL MODEL; BODY WEIGHT; FEEDING; FOOD INTAKE; HUMAN; HYPOTHALAMUS; MOUSE; NONHUMAN; OBESITY; PATHOGENESIS; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; RAT; REVIEW;

ANIMALS; APPETITE; BODY WEIGHT; CORTICOTROPIN-RELEASING HORMONE; DRUG INTERACTIONS; HUMANS; LEPTIN; MELANOCYTE-STIMULATING HORMONES; NEUROPEPTIDE Y; OBESITY;

ANIMALIA;

EID: 0035177544     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.354     Document Type: Review

References (61)

1. Drug therapy for obesity
2. Current and potential drugs for treatment of obesity
3. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight
4. Peripheral and central mechanisms regulating food intake and macronutrient selection
5. Central nervous system control of food intake
6. Leptin, leptin receptors, and the control of body weight
7. Leptin: Fundamental aspects
8. Animal models of obesity and their usefulness in molecular approach to obesity
9. The new biology of body weight regulation
10. Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat
11. Abnormal splicing of the leptin receptor in diabetic mice
12. The weight-reducing effect of an intracerebroventricular bolus injection of leptin in genetically obese fa/fa rats. Reduced sensitivity compared with lean animals
13. The MONA LISA hypothesis in the time of leptin
14. Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects during short-term fasting
15. Clinical aspects of leptin
16. Congenital leptin deficiency is associated with severe early-onset obesity in humans
17. Identification of SOCS-3 as a potential mediator of central leptin resistance
18. Decreased cerebrospinal-fluid/serum leptin ratio in obesity. A possible mechanism for leptin resistance
19. The biology of leptin: A review
20. Recombinant leptin for weight loss in obese and lean adults: A randomized, controlled, dose-escalation trial
21. Neurobiology and clinical aspects of neuropeptide Y
22. Role of hypothalamic neuropeptide Y in feeding and obesity
23. Neuropeptide Y: A central regulator of energy homeostasis
24. Adrenal steroid receptors: Interactions with brain neuropeptide systems in relation to nutrient intake and metabolism
25. K(+)-stimulated neuropeptide Y release into the paraventricular nucleus and relation to feeding behavior in free-moving rats
26. Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion
27. Evidence that neuropeptide Y is a physiological signal for normal food intake
28. Central control of feeding behavior by neuropeptide
29. Interactions between the neuropeptide Y system and the hypothalamic-pituitary-adrenal axis
30. Evidence for a central mechanism of obesity in the Zucker rat: Role of neuropeptide Y and leptin
31. Neuropeptide Y receptors: Are multiple subtypes involved?
32. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y
33. Screening for mutations in the neuropeptide Y Y5 receptor gene in cohorts belonging to different weight extremes
34. Genetic studies of neuropeptide Y and neuropeptide Y receptors Y1 and Y5 regions in morbid obesity
35. Corticotropin-releasing factor (CRF) and its role in the central nervous system
36. Neuroendocrine regulation of food intake
37. New approaches in the pharmacological treatment of obesity
38. The role of corticotropin-releasing factor and urocortin in the modulation of ingestive behavior
39. 2 receptors in corticotropin-releasing factor- and urocortin-induced anorexia
40. CRF-binding protein and obesity
41. Two important systems in energy homeostasis: Melanocortins and melanin-concentrating hormone
42. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome
43. Discovery of a novel superpotent and selective melanocortin-4 receptor antagonist (HS024): Evaluation in vitro and in vivo
44. Targeted disruption of the melanocortin-4 receptor results in obesity in mice
45. Melanocortin receptors: Perspectives for novel drugs
46. Long-term orexigenic effects of AgRP-(83-132) involve mechanisms other than melanocortin receptor blockade
47. Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting
48. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein
49. Upregulation of adipocyte metabolism by agouti protein: Possible paracrine actions in yellow mouse obesity
50. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POM mutations in humans
51. Brief report impaired processing of prohormones associated with abnormalities of glucose homeostasis and adrenal function
52. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase gene
53. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans
54. CART, a new anorectic peptide
55. CART peptides: Novel addiction- and feeding-related neuropeptides
56. Orexins and orexin receptors: Implication in feeding behavior
57. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y
58. Propiomelanocortin neurons are direct targets for leptin in the hypothalamus
59. Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and corrected in ob/ob and db/db mice, but is stimulated by leptin
60. Melanocortin receptors in leptin effects
61. A risk-benefit assessment of antiobesity drugs